Commentary on the Association of Symptoms Associated With Gadolinium Exposure/Gadolinium Deposition Disease and Gadolinium-Based Contrast Agents

From the ∗Richard Semelka, MD, Consulting PLLC, Chapel Hill, NC †Department of Radiology, Hospital da Luz, Lisbon ‡Department of Radiology, Hospital Garcia de Orta, EPE, Almada, Portugal. Received for publication March 17, 2022; and accepted for publication, after revision, March 20, 2022. Conflicts of interest and sources of funding: none declared. Correspondence to: Richard C. Semelka, MD, 3901 Jones Ferry Rd, Chapel Hill, NC, 27516. E-mail: [email protected].